Wall Street Investment Opportunity: Johnson and Johnson
Biotech giant Johnson and Johnson (JNJ) maybe on the edge of double-digit top line growth. New products, innovation and strategic acquisitions are expected to accelerate JNJ's growth and appreciate the company's stock value by 22 to 39 percent over the next 12 months.
